AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

0.04% of the stock is currently owned by insiders. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, ...

While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

The jobs include roles in engineering and technical services and global supply chain functions. Read more at straitstimes.com ...

The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with this FTSE 100 ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be implicated in the largest insurance fraud case ...

Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...